| Quote: | |  | |
| EU Advance Purchase Agreement of 200 million Pfizer doses in September 2020 financed with the Emergency Support Instrument, which has funds dedicated to the creation of a portfolio of potential vaccines with different profiles and produced by different companies.
That is more than $445 million, usually, your posts are more accurate. 
Let us not forget there was the European Investment Bank EU guaranteed loan in June to provide Pfizer partner BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing. | |
| | |
By September 2020 the vaccine was already pretty much developed. Anyway, 200 milllion is a low amount per head. Less per capita than the UK ordered.
Likewise, the US, with a much smaller population has ordered 200m.
If the EU didn't exist - the member states would probably have ordered more on this basis. So I think the EU has actually removed funds from Pfizer if anything.